- Repaglinide - (https://www.ncbi.nlm.nih.gov/books/NBK559305/ )
- Effect of combination therapy with repaglinide and metformin hydrochloride on glycemic control in Japanese patients with type 2 diabetes mellitus - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025226/ )
- Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116761/ )
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Restrict (0.5mg) - East West Pharmaceuticals Pvt. Ltd.
Restrict (0.5mg) Tablet
Generic : Repaglinide
Substitute/Alternative Medication to Restrict (0.5mg)
When is Restrict (0.5mg) prescribed?
It is prescribed for -